Effects of allopurinol, a xanthine oxidase inhibitor, and sulfinpyrazone upon the urinary and serum urate concentrations in eight patients with tophaceous gout.
D000368:Aged; D001769:Blood; D004357:Drug Synergism; D057487:Enzyme Therapy; D006073:Gout / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D011743:Pyrimidines / Q000627:therapeutic use*; D013442:Sulfinpyrazone / Q000627:therapeutic use*; D014527:Uric Acid / Q000378:metabolism*; D014556:Urine; D014969:Xanthine Oxidase / Q000627:therapeutic use*
D011743:Pyrimidines; D014527:Uric Acid; D014969:Xanthine Oxidase; D013442:Sulfinpyrazone